Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would ...
Investing.com -- Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares starting to trade at $16.12. The company priced 8,750,000 ...
PulteGroup (NYSE:PHM – Get Free Report) announced that its board has initiated a stock buyback program on Thursday, January 30th, RTT News reports. The company plans to repurchase $1.50 billion in ...
Hilltop Holdings boosted its quarterly payout to investors and authorized a new stock repurchase program. The board directors increased the dividend by 5.9% to 18 cents per share from 17 cents, the ...